Anti-Phospholipid Antibodies

Test/Investigation

Anti-Phospholipid Antibodies

Site(s) or Laboratory offering Test/Investigation

NNUH (Immunology)

Units

U/mL

Also Known as/Frequency of Test

IgG Cardiolipin antibody; β-2-glycoprotein I antibody; Cardiolipin, Phospholipids, APS Ab

Indications

Anti phospholipid syndrome (APS) presents with thrombosis (arterial and venous) and recurrent miscarriage. It is more common in the context of other CTD such as SLE and antibody levels do not correlate with extent or severity of thromboses. Antibodies may occur transiently following infection. To confirm the diagnosis antibodies must be identified on 2 occasions >12 weeks apart.

Comments/Precautions

Anticardiolipin anitbodies (IgG and IgM) and Anti-beta-2-glycoprotein I antibodies (IgG and IgM) will be tested as part of this test set. Lupus anticoagulant should also be tested in these patients and this is available to request as part of the specialist coagulation repetoire.

Sample type

Serum

Turnaround times (TAT) Urgent/Routine/GP or OPD

5 working days

Reference intervals (adult unless stated)

0.0 – 10.0 U/mL Negative
10.0 –40 0.0 U/mL Equivocal
>40 U/ml Positive

If UKAS Accredited Test indicate at which site

Y NNUH